<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2012</study_start_year><condition>Neoplasms, Therapy-Associated</condition><condition>Neoplasms, Second Primary</condition><disease>Neoplasms, Therapy-associated</disease><disease>Neoplasms, Second Primary</disease><study_type>Observational patient registry</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2196095</full_dataset_link><location>China</location><study_start_month>6</study_start_month><keyword>Biomarker</keyword><keyword>Metastasis colorectal cancer</keyword><keyword>Molecular Targeted Therapy</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer</name><description>Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer and explore some biomarkers that relate to target therapy.</description><dates><creation>2012-06-15</creation></dates><accession>2196095</accession><cross_references><ClinicalTrials___gov>NCT02523495</ClinicalTrials___gov></cross_references></HashMap>